1
Jeffrey R Churchill, Francis G Hutchinson: Continuous release formulations. Imperial Chemical, Cushman Darby & Cushman, July 2, 1985: US04526938 (304 worldwide citation)

Pharmaceutical compositions comprising a pharmacologically active polypeptide and a pharmacologically or veterinarily acceptable amphipathic, non-cross-linked linear, branched or graft block copolymer, which has a minimum weight average molecular weight of 5,000, in which the hydrophobic component i ...


2
Jeffrey R Churchill, Francis G Hutchinson: Biodegradable amphipathic copolymers. Imperial Chemical, Cushman Darby & Cushman, May 17, 1988: US04745160 (137 worldwide citation)

A pharmaceutically or veterinarily acceptable amphipathic, non-cross linked linear, branched or graft block copolymer, which has a minimum weight average molecular-weight of 1000, in which the hydrophobic component is biodegradable or hydrolytically unstable under normal physiological conditions, an ...


3
Jeffrey R Churchill, Francis G Hutchinson: Continuous release formulations. Imperial Chemical, Cushman Darby & Cushman, July 17, 1990: US04942035 (66 worldwide citation)

Pharmaceutical compositions comprising a pharmacologically active polypeptide and a pharmacologically or veterinarily acceptable amphipathic, non-cross-linked linear, branched or graft block copolymer, which has a minimum weight average molecular weight of 5,000, in which the hydrophobic component i ...


4
Jeffrey R Churchill, Francis G Hutchinson: Biodegradable amphipathic copolymers. Imperial Chemical, Cushman Darby & Cushman, October 31, 1989: US04877606 (4 worldwide citation)

A pharmaceutically or veterinarily acceptable amphipathic, non-cross linked linear, branched or graft block copolymer, which has a minimum weight average molecular-weight of 1000, in which the hydrophobic component is biodegradable or hydrolytically unstable under normal physiological conditions, an ...